Vascular function in health and disease review series.
作者信息
Taggart Michael
出版信息
J Cell Mol Med. 2010 May;14(5):1017. doi: 10.1111/j.1582-4934.2010.01050.x. Epub 2010 Mar 9.
Abstract
摘要
相似文献
1
Vascular function in health and disease review series.健康与疾病中的血管功能综述系列
J Cell Mol Med. 2010 May;14(5):1017. doi: 10.1111/j.1582-4934.2010.01050.x. Epub 2010 Mar 9.
2
Cardiovascular biology.心血管生物学
Nature. 2011 May 19;473(7347):297. doi: 10.1038/473297a.
3
Defining vascular aging and cardiovascular risk.定义血管老化和心血管风险。
J Hypertens. 2012 Jun;30 Suppl:S3-8. doi: 10.1097/HJH.0b013e328353e501.
4
Cardiovascular effects of dietary copper deficiency.膳食铜缺乏对心血管系统的影响。
Biofactors. 1999;10(4):359-75. doi: 10.1002/biof.5520100406.
5
Impact of vascular aging on cardiovascular disease: the role of telomere biology.血管老化对心血管疾病的影响：端粒生物学的作用。
J Hypertens. 2012 Jun;30 Suppl:S9-12. doi: 10.1097/HJH.0b013e328353e512.
6
[Effects of leukocytes on vascular tonus].[白细胞对血管张力的影响]
Arzneimittelforschung. 1994 Mar;44(3A):447-50.
7
[The significance of matrix metalloproteinases in vascular biology].[基质金属蛋白酶在血管生物学中的意义]
Harefuah. 2001 Feb;140(2):134-8.
8
[Plethysmography--a clinical method of studying vascular tonus].[体积描记法——研究血管张力的一种临床方法]
Vestn Akad Med Nauk SSSR. 1967;22(4):10-9.
9
Steps ahead in the non-invasive testing of vascular function.血管功能无创检测的前沿进展。
J Hypertens. 2002 Sep;20(9):1697-8. doi: 10.1097/00004872-200209000-00005.
10
Nitric oxide and the control of human vascular tone in health and disease.一氧化氮与健康和疾病状态下人体血管张力的调控
Eur J Med. 1993 Jan;2(1):48-53.
引用本文的文献
1
Intermedin Inhibits the Ox-LDL-Induced Inflammation in RAW264.7 Cells by Affecting Fatty Acid-Binding Protein 4 Through the PKA Pathway.肾上腺髓质素通过蛋白激酶A途径影响脂肪酸结合蛋白4，抑制氧化型低密度脂蛋白诱导的RAW264.7细胞炎症反应。
Front Pharmacol. 2021 Dec 1;12:724777. doi: 10.3389/fphar.2021.724777. eCollection 2021.
2
Synthesis and cardiovascular protective effects of quercetin 7-O-sialic acid.槲皮素7-O-唾液酸的合成及其心血管保护作用
J Cell Mol Med. 2017 Jan;21(1):107-120. doi: 10.1111/jcmm.12943. Epub 2016 Aug 11.
3
Age-related changes in the contractile and passive arterial properties of murine mesenteric small arteries are altered by caveolin-1 knockout.衰老相关的变化在收缩和被动的动脉性质的鼠肠系膜小动脉是改变由窖蛋白- 1 敲除。
J Cell Mol Med. 2012 Aug;16(8):1720-30. doi: 10.1111/j.1582-4934.2011.01457.x.
本文引用的文献
1
Statin cost-effectiveness in the United States for people at different vascular risk levels.他汀类药物在美国针对不同血管风险水平人群的成本效益。
Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):65-72. doi: 10.1161/CIRCOUTCOMES.108.808469. Epub 2009 Mar 5.
2
Effects of antihypertensive treatment on small artery remodelling.抗高血压治疗对小动脉重塑的影响。
J Hypertens. 2009 Jun;27(6):1107-14. doi: 10.1097/HJH.0b013e328329272e.
3
Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study.他汀类药物治疗对中心动脉压和血流动力学的影响：导管动脉功能评估-降脂组（CAFE-LLA）研究的主要结果
Circulation. 2009 Jan 6;119(1):53-61. doi: 10.1161/CIRCULATIONAHA.108.785915. Epub 2008 Dec 22.
4
Olmesartan medoxomil in elderly patients with essential or isolated systolic hypertension : efficacy and safety data from clinical trials.奥美沙坦酯用于老年原发性或单纯收缩期高血压患者：来自临床试验的疗效和安全性数据
Drugs Aging. 2009;26(1):61-76. doi: 10.2165/0002512-200926010-00005.
5
Obesity is associated with aortic enlargement and increased stiffness: an echocardiographic study.肥胖与主动脉扩张及僵硬度增加相关：一项超声心动图研究。
Int J Cardiovasc Imaging. 2008 Feb;24(2):165-71. doi: 10.1007/s10554-007-9248-2. Epub 2007 Aug 7.
6
Cost-effectiveness of simvastatin in people at different levels of vascular disease risk: economic analysis of a randomised trial in 20,536 individuals.辛伐他汀在不同血管疾病风险人群中的成本效益：一项针对20536名个体的随机试验的经济分析
Lancet. 2005;365(9473):1779-85. doi: 10.1016/S0140-6736(05)63014-0.
Zotero 插件